Skip to main content
Clinical Trials/DRKS00013903
DRKS00013903Recruiting未知

Short term effects of nasal high flow therapy on autonomic nervous system function and respiration in patients with neuromuscular diseases

Department für Neurologie- Klinik für Schlafmedizin und neuromuskuläre Erkrankungen Universitätsklinikum Münster0 sites12 target enrollmentStarted: April 4, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
12

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • a. Age > 18 years (no age limit)
  • b. able to consent
  • c. proven NMD
  • d. ongoing nocturnal NIV therapy with a nasal mask for hypoventilation due to a NMD
  • e. good tolerance of and adherence to the ongoing NIV therapy with minimal nasal mask-related problems/discomfort
  • f. no vital indication for NIV use at night

Exclusion Criteria

  • - other severe internistic pre-existing conditions, especially insulin-dependent diabetes or severe renal impairment
  • - severe neurological pre-existing conditions such as stroke, especially brainstem infarction
  • - intake of opioids
  • - severe psychiatric pre-existing conditions

Investigators

Sponsor
Department für Neurologie- Klinik für Schlafmedizin und neuromuskuläre Erkrankungen Universitätsklinikum Münster

Similar Trials

Short term effects of nasal high flow... | Clinical Trial